June 17, 2024
IPOPI Participates in IPPC 2024 in Athens
The International Plasma Protein Congress (IPPC) took place in Athens, Greece, on April 16 and 17, 2024, bringing together global stakeholders to discuss the evolving landscape of plasma-derived medicinal products.
Johan Prevot, Executive Director of the International Patient Organisation for Primary Immunodeficiencies (IPOPI), played a significant role in the event, participating in the final panel discussion alongside Dr Silvia Sanchez-Ramon (IPOPI Medical Advisory Panel member), Prof Isabelle Durand-Zalenski, Mr Marek Migdal, and Ms Daniela Philadelphy. The panel focused on the crucial need for a more consistent approach to the use of Immunoglobulin (Ig) replacement therapies across Europe. Mr Prevot emphasised the benefits of achieving more regionally balanced plasma collection, which would have a positive impact on patient care globally.
The congress was also attended by the members of the IPOPI Board of Directors who actively participated in the Q&A sessions.
Additionally, IPOPI extends its congratulations to Dr Charlotte Cunningham-Rundles, a valued member of the IPOPI Medical Advisory Panel, for being awarded the 2024 Joachim Hilfenhaus Award. This recognition celebrates her outstanding contributions to the field of immunology and her dedication to improving patient outcomes.
The IPPC in Athens provided an important platform for addressing key issues related to plasma-derived medicinal products (PDMPs). IPOPI’s active involvement in these important discussions echoes the PID patient community’s call to increase plasma collection worldwide and optimise patient access to safe and effective IG therapies.
